【2023/5/25 更新】已恢復少量供貨。 #特殊劑型：不建議磨粉、管灌藥品

Treatment of peripheral vascular circulatory disorder.

Pentoxifylline, a synthetic xanthine derivative, is a hemorrheologic agent. The principal hemorrheologic effects of pentoxifylline in patients with peripheral vascular disease appear to be an increase in erythrocyte flexibility (deformability) and a secondary reduction in viscosity of whole blood; these effects are associated with a decrease in total systemic vascular resistance and subsequent improvement in blood flow, particularly in the microcirculation, and with increased tissue oxygenation.

Recent myocardial infarction.

C

Pentoxifylline and its metabolites are distributed into milk. Because of the tumorigenic potential exhibited by pentoxifylline in rats, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the woman.

Nausea, dizziness, and flushing.

PO: 400 mg 3 times/day with meals, may reduce to 400 mg twice daily if GI or CNS side effects occur.